Z-0247-2022 Class III Terminated
FDA device recall Z-0247-2022 was initiated by Ortho-Clinical Diagnostics, Inc. on Oct 15, 2021 and is designated Class III. Reason for recall: Ortho Clinical Diagnostics confirmed a complaint that some VITROS Immunodiagnostic Products Anti-HBc IgM Controls Lot 1690 Controls Values booklet contained information for the incorrect product… The recall status is terminated (terminated Dec 18, 2023). Affected quantity: 191 units.
Recall details
- Product Type
- Devices
- Report Date
- Nov 24, 2021
- Initiation Date
- Oct 15, 2021
- Termination Date
- Dec 18, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 191 units
Product description
VITROS Immunodiagnostic Products Anti-HBc IgM Controls, Product Code 6801427 For use in monitoring the performance of the VITROS ECi/ECiQ/3600 Immunodiagnostic Systems and the VITROS 5600/XT 7600 Integrated Systems
Reason for recall
Ortho Clinical Diagnostics confirmed a complaint that some VITROS Immunodiagnostic Products Anti-HBc IgM Controls Lot 1690 Controls Values booklet contained information for the incorrect product. While the accuracy of patient test results is not affected by this issue, there is a potential for delayed results due to the troubleshooting of Quality Control results.
Distribution pattern
US (Domestic) distribution to states of: AZ, CA, CO, CT, FL, GA, LA, MA, MO, NJ, NY, OK, SC, SD, TX, UT, WA, WI, and WV. OUS (Foreign) distribution to Colombia.
Code information
Lot 1690 UDI 10758750001200
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0247-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026